Omega-3 slows biological ageing in older adults

Daily omega-3 slowed biological ageing over three years, with added benefits seen when combined with vitamin D and regular exercise in healthy older adults, based on DNA methylation clocks.

How to use breathwork to enhance your VO2 max

Boost your VOâ‚‚ max and overall fitness through targeted breathwork techniques like segmental breathing and thoracic expansion. These practices strengthen respiratory muscles, improve oxygen efficiency, and support better exercise performance, endurance, and long-term health.

Healthy bones, happy life: Why bone health matters

Strong bones are key to staying active, independent, and well as you age. Learn how osteogenic loading can safely stimulate bone growth and support your health goals, plus enjoy a special offer through Melbourne Functional Medicine.

High-dose vitamin D boosts muscle over fat

High-dose vitamin D redirects surplus calories towards muscle growth and away from fat storage by modulating myostatin and leptin signalling. This promotes lean mass, strength, and linear growth without increasing overall weight, offering a new framework for enhancing body composition, energy balance, and metabolic health across the lifespan.

Living higher, ageing slower: the altitude effect

Higher altitude living in Ethiopia is linked to lower disease burden, reduced DNA damage-related senescence, and longer life expectancy, despite signs of increased facial ageing from UV exposure.

Senescent cell clearance and flu: what the latest research reveals

Senolytic therapies reduced immune cell infiltration in the lungs of aged mice with influenza A, but did not improve illness severity or survival. Despite targeting ageing-related senescence, these short-term treatments failed to reverse immune dysfunction, suggesting senolytics may not offer universal benefits across all respiratory infections in later life.

The unseen toll of sugar-sweetened beverages worldwide

Regular consumption of sugar-sweetened drinks was linked to over 3 million new diabetes and heart disease cases globally in 2020, with the highest burdens in Latin America and sub-Saharan Africa. Younger, urban, and more educated adults were most affected, highlighting urgent need for targeted prevention and policy action.

SGLT2 inhibitors show promise for longevity and disease prevention

SGLT2 inhibitors, originally for type 2 diabetes, show broad potential to slow ageing, prevent age-related diseases, and extend healthspan and lifespan. They enhance autophagy, reduce oxidative stress, rejuvenate mitochondria, and protect against heart, kidney, brain, and metabolic decline, even in non-diabetics, with a strong safety profile.